Judge dismisses test case on third generation pillBMJ 2002; 325 doi: https://doi.org/10.1136/bmj.325.7358.237 (Published 03 August 2002) Cite this as: BMJ 2002;325:237
- Clare Dyer, legal correspondent
Third generation contraceptive pills, whose sales plummeted after the 1995 “pill scare,” carry no higher risks of venous thromboembolism than second generation pills, a high court judge ruled this week.
Mr Justice Mackay made his ruling in a group action by 99 women against three manufacturers of third generation oral contraceptives—Schering Health Care, Organon Laboratories, and John Wyeth and Brother. The women, who had strokes, pulmonary embolisms, and deep vein thromboses, argued that the newer pills were defective products as defined by the Consumer Protection Act.
The judge described the 42 days of expert evidence …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial